However, it is not until pSTAT3 levels become dysregulated that sustained increases in XRCC1 expression and subsequently changes in BER and SSBR would be observed, contributing to chemoresistance and tumor aggressiveness. This evidence concerns the gene XRCC1 and neoplasm.